Brian culley ceo
WebThe latest tweets from @CEO_Culley WebMar 11, 2024 · Formerly Known As BioTime, Inc., BioTime Incorporated Ownership Status Publicly Held Financing Status Corporation Primary Industry Pharmaceuticals Other Industries Drug Discovery Stock Exchange ASE Primary Office 2173 Salk Avenue Suite 200 Carlsbad, CA 92008 United States +1 (442) 000-0000 Want detailed data on 3M+ …
Brian culley ceo
Did you know?
WebAug 18, 2016 · Culley is the CEO of Mast Therapeutics Inc (NYSE: MSTX ), a biopharmaceutical company focused on treating life-threatening conditions such as sickle cell disease and heart failure. 9. Christian... WebJan 5, 2024 · Brian Culley, CEO at Lineage Cell Therapeutics Mr. Culley has more than 25 years of business and scientific experience in the life sciences industry. Prior to joining Lineage, Mr. Culley served from August 2024 to September 2024 as interim Chief Executive Officer at Artemis Therapeutics, Inc. (ATMS).
WebCulley previously served as Chief Executive Officer of Mast Therapeutics, Inc. (MSTX), from 2010, and was also a member of its board of directors from 2011, until Mast’s merger with Savara, Inc. (SVRA) in April 2024. Mr. WebOct 20, 2024 · CEO: Brian Culley Headquarters: Carlsbad Business: Cell therapies Employees: 75 Stock: LCTX (NYSE American) Revenue: $3.89 million (2024) Website: lineagecell.com Notable: Lineage is the only company that has shown retinal restoration using stem cells. Previous article Maravai Reinstates Co-Founder Hull as CEO Next …
WebJan 20, 2024 · Mr. Brian Culley, Lineage’s Chief Executive Officer, will serve as Interim Chief Financial Officer until a new Chief Financial Officer has been appointed. WebMar 20, 2024 · Brian Culley has been working as a Chief Executive Officer & Interim Chief Financial Officer at Lineage Cell Therapeutics for 5 years. Lineage Cell Therapeutics is part of the Business Services industry, and located in California, United States. Lineage Cell Therapeutics Location 2173 Salk Ave Ste 200, Carlsbad, California, 92008, United …
WebMar 20, 2024 · Brian Culley Current Workplace. Brian Culley has been working as a Chief Executive Officer & Interim Chief Financial Officer at Lineage Cell Therapeutics for 5 …
WebOct 16, 2024 · “Manufacturing cells is not like manufacturing small molecules,” Brian Culley, CEO of Lineage Cell Therapeutics, told BioSpace. “For cell therapy products to mature into ‘real’ products that deliver on the promises of 10 years ago, they must be scalable – which drives affordability – and they must solve their purity issues.” compatibility\u0027s hfWebFeb 2, 2024 · Principal: Brian Culley, CEO Number of Employees: 60 Focus: A clinical-stage biotechnology company that develops novel cell therapies for unmet medical needs. Lineage’s programs are based on its proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. compatibility\u0027s heWebCreator and Host of BioTech IQ Ammon Rivera sits down with Lineage Cell Therapeutics CEO, Brian Culley. Interview originally recorded on June 7th 2024.Lineag... compatibility\u0027s hgWebCasually evaluating opportunities to lead a new project and/or team as interim, contingent, or full-time CEO. I have extensive experience acquiring assets (4 M&A deals), raising capital (>$150M ... eb financial holdingsWebMar 23, 2024 · Brian Culley, CEO of Lineage Cell Therapeutics, discusses developing and commercializing therapies to treat degenerative diseases and adjusting to global supply … compatibility\u0027s hjWebChief Executive Officer Brian Culley. Mr. Culley joined Lineage as Chief Executive Officer in September 2024. Prior to joining Lineage, Mr. Culley served from August … e bff ayWebMar 13, 2024 · Lineage Cell Therapeutics, Inc. (NYSE:NYSE:LCTX) Q4 2024 Earnings Conference Call March 12, 2024 4:30 PM ETCompany ParticipantsIoana Hone - Director of Investor RelationsBrian Culley -... ebf.myportallogin.com